The ALK inhibitor ASP3026 eradicates NPM-ALK+ T-cell anaplastic large-cell lymphoma <i>in vitro</i> and in a systemic xenograft lymphoma model
Suraj K. George(The University of Texas MD Anderson Cancer Center), Hesham M. Amin(The University of Texas MD Anderson Cancer Center)
Cited by 28
Related Papers
Constitutive Activation of JAK3/STAT3 in Colon Carcinoma Tumors and Cell Lines
|American Journal Of Pathology|2005|207
MicroRNA 96 Is a Post-Transcriptional Suppressor of Anaplastic Lymphoma Kinase Expression
|American Journal Of Pathology|2012|53
The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK+ T-cell lymphoma
|Molecular Cancer|2015|27